United States· US:47335-667_a9910c38-e099-4f8a-a7e9-a88623be2032
risedronate sodium
A medicinal product containing risedronate sodium hemi-pentahydrate, registered in United States by Sun Pharmaceutical Industries, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RISEDRONATE SODIUM HEMI-PENTAHYDRATE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc114733566708100 TABLET, FILM COATED in 1 BOTTLE (47335-667-08)
- ndc1147335667181000 TABLET, FILM COATED in 1 BOTTLE (47335-667-18)
- ndc11473356678330 TABLET, FILM COATED in 1 BOTTLE (47335-667-83)
- ndc114733566788100 TABLET, FILM COATED in 1 BOTTLE (47335-667-88)
- ndc1147335-667-08
- ndc1147335-667-18
- ndc1147335-667-83
- ndc1147335-667-88
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Risedronate sodium hemi-pentahydrate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Cyprus · Atronate
- Spain · Arisocare, Risedronato Stada
- France · Risedronate Biogaran, Risedronate Cristers Pharma
- United Kingdom (Northern Ireland) · Risedronate Sodium
- Greece · Palibone, Risosfon
- Italy · Cedravis, Fodren
- Portugal · Risedronato De Sódio Bluepharma, Risedronato De Sódio Farmoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e751016a-f371-4e6c-8ce0-2905bf912484 GET /v1/drugs/e751016a-f371-4e6c-8ce0-2905bf912484?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "RISEDRONATE SODIUM HEMI-PENTAHYDRATE",
"productndc": "47335-667",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA090886",
"marketing_category": "ANDA"
}See everything about risedronate sodium hemi-pentahydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.